MRK

Merck News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.37 0.44% 83.75 07:38:48
Open Price Low Price High Price Close Price Prev Close
83.38
more quote information »

Recent News

Date Time Source Heading
1/18/20219:01IHNWFeaturedMANGANESE X ANNOUNCES WARRANT LISTING
1/12/202107:38DJNMerck Gets FDA Priority Review of V114 Vaccine for Adults
1/12/202106:45BWU.S. FDA Accepts for Priority Review the Biologics License..
1/08/202106:45BWMerck to Hold Fourth-Quarter and Full-Year 2020 Sales and..
1/07/202116:56EDGARInitial Statement of Beneficial Ownership (3)
1/06/202110:04DJNCEOs Consider Ways to Smooth the Presidential Transition,..
1/05/202116:28EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202116:25EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202116:24EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202106:45BWMerck to Present at the 39th Annual J.P. Morgan Healthcare..
12/28/202010:42TRMNAstraZeneca, Merck’s Lynparza Wins Approval in Japan For..
12/28/202006:45BWLYNPARZA® (olaparib) Receives Three New Approvals in Japan
12/23/202009:15TRMNMerck Signs Supply Agreement with U.S. Government for..
12/23/202007:33DJNCorrection to Merck Article
12/23/202007:26DJNMerck to Supply U.S. With Covid-19 Therapeutic
12/23/202006:45BWMerck Announces Supply Agreement with U.S. Government for..
12/17/202007:39DJNMerck: FDA Grants Priority Review to Keytruda Plus..
12/17/202006:45BWFDA Grants Priority Review to Merck’s Supplemental Biologics..
12/16/202006:45BWKEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib)..
12/11/202008:04DJNMerck Gets Positive Opinion From EU's CHMP on Keytruda for..
12/11/202007:10BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
12/10/202018:14DJNTop CEOs Back Push to Create One Million Jobs for Black..
11/30/202006:45BWMerck to Present at the 2020 Evercore ISI 3rd Annual..
11/23/202009:06PRNUSMerck Animal Health Survey Reveals First-Time Dog Owners..
11/23/202008:37DJNCorrection to Merck to Buy OncoImmune Article
11/23/202008:25DJNMerck to Buy OncoImmune for $425 Million Amid Race for..
11/23/202007:30DJNMerck Applies in U.S., Europe to License V114 Pneumococcal..
11/23/202007:14DJNMerck to Buy OncoImmune Amid Covid-19 Vaccine Development
11/23/202006:47BWMerck Submits Applications for Licensure of V114, the..
11/23/202006:45BWMerck to Acquire OncoImmune
11/17/202014:04DJNMerck Lifts Quarterly Dividend to 65 Cents a Share
11/17/202013:25BWMerck Announces First-Quarter 2021 Dividend
11/16/202020:05DJNBerkshire Hathaway Invests in Drugmakers Seeking Covid-19..
11/16/202019:37DJNBerkshire Hathaway Invests in Drugmakers Seeking Covid-19..
11/16/202019:29DJNBerkshire Hathaway Invests in Drugmakers Seeking Covid-19..
11/16/202007:27DJNMerck to Begin Late-Stage Trial of HIV Prevention Drug, With..
11/16/202006:45BWMerck Advances Phase 3 Trial to Evaluate Investigational..
11/13/202016:10BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) in..
11/12/202016:46EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202006:45BWKEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib)..
11/09/202016:10BWMerck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA®..
11/05/202016:58EDGARQuarterly Report (10-q)
11/05/202010:36DJNAstraZeneca, Merck Get Europe OK for Two New Lynparza..
11/05/202008:23DJNMerck & Co. to Buy VelosBio for $2.75 Billion in Cash
11/05/202006:52PRNUSPappas Capital Portfolio Company VelosBio to be Acquired by..
11/05/202006:45BWLYNPARZA® (olaparib) in Combination with Bevacizumab..
11/05/202006:30BWMerck to Acquire VelosBio
11/03/202016:48EDGARStatement of Changes in Beneficial Ownership (4)
11/01/202009:29DJNDrone Startups Aim to Carve Out Role in Delivery of..
10/27/202007:52DJNMerck Raises 2020 Adjusted EPS Guidance, Narrows Revenue..
10/27/202007:26DJNMerck 3Q Profit Rises; Minimal Pandemic Disruption to..
See more news about this stock »


Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.